These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2763444)

  • 1. Infectivity of cryopreserved Babesia bovis, Babesia bigemina and Anaplasma centrale for cattle after thawing, dilution and incubation at 30 degrees C.
    Jorgensen WK; de Vos AJ; Dalgliesh RJ
    Vet Parasitol; 1989 Jun; 31(3-4):243-51. PubMed ID: 2763444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-thawing viability of vaccines for bovine babesiosis and anaplasmosis cryopreserved with glycerol.
    Mangold AJ; Aguirre DH; Guglielmone AA
    Vet Parasitol; 1990 Nov; 37(3-4):301-6. PubMed ID: 2267730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and laboratory testing of a frozen vaccine containing Babesia bovis, Babesia bigemina and Anaplasma centrale.
    Mellors LT; Dalgliesh RJ; Timms P; Rodwell BJ; Callow LL
    Res Vet Sci; 1982 Mar; 32(2):194-7. PubMed ID: 7079601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viability after thawing and dilution of simultaneously cryopreserved vaccinal Babesia bovis and Babesia bigemina strains cultured in vitro.
    Mangold AJ; Vanzini VR; Echaide IE; de Echaide ST; Volpogni MM; Guglielmone AA
    Vet Parasitol; 1996 Feb; 61(3-4):345-8. PubMed ID: 8720572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging perspectives in the research of bovine babesiosis and anaplasmosis.
    Suarez CE; Noh S
    Vet Parasitol; 2011 Aug; 180(1-2):109-25. PubMed ID: 21684084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the infectivity of Babesia bovis, Babesia bigemina and Anaplasma centrale for cattle after cryopreservation in either dimethylsulphoxide (DMSO) or polyvinylpyrrolidone (PVP).
    Standfast NF; Jorgensen WK
    Aust Vet J; 1997 Jan; 75(1):62-3. PubMed ID: 9034504
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccines against hemoparasitic diseases in Israel with special reference to quality assurance.
    Pipano E
    Trop Anim Health Prod; 1997 Nov; 29(4 Suppl):86S-90S. PubMed ID: 9512751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization against anaplasmosis and babesiosis. Part II. Evaluation of cryo-preserved vaccines using different doses and routes of inoculation.
    Todorovic R; Gonzalez E; Lopez G
    Tropenmed Parasitol; 1978 Jun; 29(2):210-4. PubMed ID: 675843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collection and sterilization of large volumes of bovine serum and its use in vaccines against bovine babesiosis and anaplasmosis.
    Rodwell BJ; Timms P; Parker RJ
    Aust J Exp Biol Med Sci; 1980 Apr; 58(2):143-7. PubMed ID: 7436873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Babesial antibody dynamics after cattle immunisation with live vaccines, measured with an indirect immunofluorescence test.
    Guglielmone AA; Lugaresi CI; Volpogni MM; Anziani OS; Vanzini VR
    Vet Parasitol; 1997 Jun; 70(1-3):33-9. PubMed ID: 9195707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tick-borne diseases of cattle in Paraguay. II. Immunisation against anaplasmosis and babesiosis.
    Payne RC; Osorio O; Ybañez A
    Trop Anim Health Prod; 1990 May; 22(2):101-8. PubMed ID: 2196724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field challenge of cattle vaccinated with a combined Babesia bovis and Babesia bigemina frozen immunogen.
    Alvarez JA; Ramos JA; Rojas EE; Mosqueda JJ; Vega CA; Olvera AM; Figueroa JV; Cantó GJ
    Ann N Y Acad Sci; 2004 Oct; 1026():277-83. PubMed ID: 15604506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field observations on the duration of immunity in cattle after vaccination against Anaplasma and Babesia species.
    Tjornehoj K; Lawrence JA; Whiteland AP; Kafuwa PT
    Onderstepoort J Vet Res; 1996 Mar; 63(1):1-5. PubMed ID: 8848296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming constraints to meeting increased demand for Babesia bigemina vaccine in Australia.
    Standfast NF; Bock RE; Wiecek MM; deVos AJ; Jorgensen WK; Kingston TG
    Vet Parasitol; 2003 Jul; 115(3):213-22. PubMed ID: 12935736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live vaccines against hemoparasitic diseases in livestock.
    Pipano E
    Vet Parasitol; 1995 Mar; 57(1-3):213-31. PubMed ID: 7597786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and efficacy of Australian tick-borne disease vaccine strains in cattle in Paraguay.
    Brizuela CM; Ortellado CA; Sanabria E; Torres O; Ortigosa D
    Vet Parasitol; 1998 Mar; 76(1-2):27-41. PubMed ID: 9653988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology of Babesia species, Theileria parva, and Anaplasma marginale infecting cattle and the tick control malpractices in Central and Eastern Uganda.
    Tayebwa DS; Vudriko P; Tuvshintulga B; Guswanto A; Nugraha AB; Gantuya S; Batiha GE; Musinguzi SP; Komugisha M; Bbira JS; Okwee-Acai J; Tweyongyere R; Wampande EM; Byaruhanga J; Adjou Moumouni PF; Sivakumar T; Yokoyama N; Igarashi I
    Ticks Tick Borne Dis; 2018 Sep; 9(6):1475-1483. PubMed ID: 30017724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization against anaplasmosis and babesiosis: Part I. Evaluation of immunization using minimum infective doses under laboratory conditions.
    González EF; Todorovic RA; Thompson KC
    Tropenmed Parasitol; 1976 Dec; 27(4):427-37. PubMed ID: 1006801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine babesiosis and anaplasmosis follow-up on cattle relocated in an endemic area for hemoparasitic diseases.
    Figueroa JV; Alvarez JA; Ramos JA; Rojas EE; Santiago C; Mosqueda JJ; Vega CA; Buening GM
    Ann N Y Acad Sci; 1998 Jun; 849():1-10. PubMed ID: 9668444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis for vaccine development against anaplasmosis and babesiosis.
    Palmer GH; McElwain TF
    Vet Parasitol; 1995 Mar; 57(1-3):233-53. PubMed ID: 7597787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.